期刊文献+

靶向肿瘤新生血管的顺磁性纳米脂质体在MRI诊断肺癌中的研究 被引量:10

Study on angiogenesis-targeting paramagnetic nanoliposomes in MRI for diagnosis of pulmonary carcinoma
下载PDF
导出
摘要 目的:构建以肿瘤新生血管为靶向的顺磁性纳米脂质体,通过对荷瘤裸鼠模型行MRI以观察其在探查微小肿瘤病灶方面的应用价值。方法:靶向多肽-脂肪酸接枝物采用9-芴甲氧羰基(fiuorenylmethoxy carbony,Fmoc)固相合成法获得,薄膜超声法制备靶向纳米脂质体,超滤离心法测定钆双胺(Gd—DPTA—BMA)包封率;激光粒度分析仪测定平均粒径;偶氮氯膦Ⅲ比色法测定钆含量;对肺腺癌A549裸鼠移植瘤模型行MRI,评价靶向纳米脂质体对肿瘤特异性MRI信号增强作用。结果:分别制备获得以整合素αVβ3、血管内皮生长因子受体(vascular endothdial growth factor receptor,VEGFR)-1、VEGFR-2为靶点的及不同连接方式的靶向纳米脂质体,包封率为55.5%-60.1%;平均粒径为109~128nm,其中以整合素受体αVβ3和VEGFR-2为靶点分子的顺磁性纳米脂质体在裸鼠移植瘤模型中显示出良好的肿瘤特异性MRI成像信号增强作用,尤以整合素受体为佳;其中连接臂又以采用疏水性连接臂6-氨基己酸效果最好。MRI T1加权像上肿瘤信号强度明显增强,可达对照的1.8—2.8倍,并清晰显示直径为2—5mm的微小肿瘤病灶;体内生物分布测定表明,肿瘤部位Gd^3+浓度高于心脏、肺、肝脏、肌肉等器官,也略高于脾脏和肾脏。结论:构建的靶向顺磁性纳米脂质体具有肿瘤特异性,肿瘤部位持续时间长,MRI信号强度高。可清晰显示直径2—5mm微小肿瘤病灶,有可能发展成为新的肿瘤特异性磁共振对比剂。 Objectives:To construct tumor angiogenesis-targeting paramagnetic liposomes and investigate their potential value as a magnetic resonance imaging (MRI) to detect minute tumor foci in tumor-bearing nude mice. Methods: Peptide-palmitic acid conjugate was prepared using fluorenylmethoxy carbony (Fmoc) solid-phase synthetic method. Angiogenesis-targeting paramagnetic liposome particles were prepared by the thin film dispersion-sonication method. Entrapped efficiency of Gd-DPTA-BMA was determined by cen- trifugal uhrafihration. The average size of liposome particles was determined by laser particle sizing analysis. Gd^3+ concentration was determined by chlorophosphonazo Ⅲ calorimetry. The signal enhancement ratio of targeted paramagnetic liposome particles was evaluated by MRI in human lung adenocarcinoma implanted in nude mice. Results:Five paramagnetic liposome particles which targeted αVβ3, vascular endothelial growth factor receptor (VEGFR) -1 and -2 and had different conjugation forms were prepared. Entrapped ef- ficiency of the five prepared paramagnetic liposome particles was from 55.5% to 60.1% , and average particle size was from 109-128 nm. Integrin αVβ3 and VEGFR-2-targeted paramagnetic liposome particles showed good tumor-specific MRI signal enhancement in xenograft of the nude mice, especially for Integrin αVβ3 receptor. Spacer 6-aminohexanoic acid demonstrated the better signal enhancement than the other two linkages. Tumor relative signal intensity was increased 1.8-2.8 folds than control in T1 weighted MR imaging. Minute tumor nodules (2-5 mm) were clearly identified. Biodistribution analysis showed that the Gd^3+ concentration in tumor was significantly higher than that in the heart, lung, liver, and muscle, and slightly higher than that in the spleen and kidney. Conclusion: Angiogenesis-targeting paramagnetic liposome particles were tumor-specific and lasted for a long time. MRI signal enhancement was higher and minute tumor foci (2-5 mm) were clearly identified. It can be developed as a potential tumor-specific MRI contrast agent for the early diagnosis of cancer and metastases.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第6期494-497,共4页 Tumor
基金 上海市自然科学基金资助项目(编号:072R14124) 上海市纳米专项基金资助项目(编号:0752nm018)
关键词 肺肿瘤 磁共振成像 新生血管化 病理性 纳米技术 顺磁性 Long neoplasms Magnetic resonance imaging Neovascularization, pathologic Nanotechnology Paramagnetic
  • 相关文献

参考文献10

  • 1BARRETT T, BRECHBIEL M, BERNARDO M, et al. MRI of tumor angiogenesis [ J ]. J Magn Reson Imaging, 2007, 26 ( 2 ) : 235 -249.
  • 2徐清华,粟波,赵印敏,唐亮,周彩存.^(131)Ⅰ标记血管靶向分子在肿瘤显像中的应用[J].肿瘤防治研究,2007,34(11):860-863. 被引量:5
  • 3PETER H, MIRIAM B, TINA V, et al. Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells [ J ]. Protein Engineering Design and Selection, 2004, 17(5) :433-441.
  • 4LEI H, AN P, SONG S, et al. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor [ J ]. J Biol Chem, 2002, 277 ( 45 ) : 43137- 43142.
  • 5AN P, LEI H, ZHANG J, et al. Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library[J], Int J Cancer,2004,111(2) :165-173.
  • 6贵金属及其合金化学分析方法:金合金中钆量的测定[M].中华人民共和国国家标准,GB/T15072.11-94.
  • 7MCDONALD D M, CHOYKE P L. Imaging of angiogenesis : from microscope to clinic[J]. Nat Med,2003, 9(6) :713-725.
  • 8MULDER W J, STRIJKERS G J, HABETS J W, et al. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle[ J ]. FASEB J, 2005,19(14) :2008-2010.
  • 9ANNE M M, PATRICK M W, KATHRYN C C, et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI[J]. Magn Reson Med, 2004 , 51 (3) :480-486.
  • 10HALLAHAN D, GENG L, QU S, et al. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels[ J]. Cancer Cell,2003 , 3 ( 1 ) : 63-74.

二级参考文献9

  • 1Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nat Med, 1995,1 (1) : 27-31.
  • 2Folkman J. Addressing tumor blood vessels[J]. Nature Biotechnol, 1997,15(6) :510.
  • 3Luttun A, Autiero M, Tjwa M, et al. Genetic dissection of tumor angiogenesis: Are PIGF and VEGFR-1 novel anti-cancer targets? [J]. Biochem Biophys Acta,2004,1654( 1 ) : 79-74.
  • 4Boyer SJ. Small molecule inhibitors of KDR(VEGFR-2) kinase: an overview of structive activity relationships[J]. Curr Top Med Chem, 2002,2 (9) : 973-1000.
  • 5Holig P, Bach M, Volkel T, et al. Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells[J]. Protein Engineering, Desing & Selection,2004,17(5) :433-441.
  • 6An P, Lei H, Zhang J, et al. Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library[J]. Int J Cancer, 2004, 111 (2) : 165- 173.
  • 7Hetian L, Ping A, Shumei S,et al. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor[J]. J Biol Chem, 2002, 277(45) : 43137-43142.
  • 8Jain RK. The next frontier of molecular medicine: delivery of therapeutics[J]. Nat Med, 1998 ,4(6) :655-657.
  • 9Dutour A, Rigaud M. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies[J]. Anticancer Res, 2(105,25(6B) :3799- 3807.

共引文献4

同被引文献106

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部